CHINA STARCH (03838) spent 34,600 Hong Kong dollars to repurchase 200,000 shares on March 25th.
China Starch (03838) announced that it will spend 34,600 Hong Kong dollars to repurchase 200,000 shares on March 25, 2026.
CHINA STARCH (03838) issued an announcement to repurchase 200,000 shares at a cost of HK$34,600 on March 25, 2026.
Related Articles
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
SHENZHENEXPRESS (00548) announced that its net profit attributable to shareholders for the year 2025 is approximately 1.149 billion yuan, an increase of 0.38% year-on-year.
NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.
China Life Insurance plans to invest 2.8 billion yuan to participate in the establishment of Fujian Province Xinrui Science and Technology Innovation Relay Equity Investment Fund.
SHENZHENEXPRESS (00548) announced that its net profit attributable to shareholders for the year 2025 is approximately 1.149 billion yuan, an increase of 0.38% year-on-year.
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026
